37 episodes
Ripples Clare English
-
- Society & Culture
This is about the ripple effects that come in the wake of big decisions or events. The current pandemic is having a dreadful effect on everyone but there is one group of vulnerable people it’s hitting particularly hard. Cancer patients. How can they cope when they don’t know if/ when they’ll get their treatment? Are they being pushed to the back of the queue? What else can the NHS do as it is struggling to cope with this unprecedented crisis? I’ll be asking some of the people involved.
-
Bye-bye….. for now!
For the #forgotten500k the waiting goes on. In this podcast which incorporates the last in the series of virtual village greens Clare is joined by Dr Lennard Lee and a clutch of familiar faces and voices. On their agenda -updates about Supernova, NICE, UK inquiry, Stravinsky…. yes….but not quite as you’d expect and an intriguing tweet from the government health, Minister .
-
Post-Christmas catch up… What you need to know
We haven’t been live streaming or podcasting for a few weeks so this is our chance to catch up on developments and there have been quite a few! Expert panel on hand to tell us about an imminent NICE decision and the factors that might influence the direction they go in, plus how it feels to be getting Evusheld on a trial.
-
It’s a wrap… For now :-)
We’re taking a short break over Christmas, but we thought it would be a good time to take stock and see how far we’ve come with the campaign to get Evusheld to the #forgotten500K. We’re also casting forward to the future to see where we can take the campaign from here and we will be back early in the New Year. Enjoy🎄
-
A clinical trial creates a buzz
There has been so much to worry us in recent weeks but now some good news on the horizon , with the advent of a new clinical trial which will combine the use of Evusheld with vaccinations for immunocompromised patients. We speak to the trial’s lead, Mark Tuthill and the panel responds to some of your questions and concerns.Hope you find it useful!
-
Stats and Westminster stasis
The waiting goes on but the campaign and the science continues amidst encouraging signs. The prestigious US publication @TIME hails Evusheld, the antibody treatment, as one of the best innovations of the year. And Dr Lennard Lee introduces us to the people who have helped him with a new report showing encouraging stats.All that and a bit of patient politics!
-
To pay or not to pay… That is the question.
A solution is out there for those who need an antibody treatment for Covid protection but it’s far from simple and not for everyone. As #theforgotten500K await a government rethink on rolling out Evusheld free in the NHS, desperate decisions are being made. Some are having to decide whether they have the finances to pay privately and that means much soul-searching. For patients without the cash they can only wait and hope that a decision will be made before Christmas.So what’s it like to have to weigh up the options? We hear from three patients and the wife of one who tell us what they’ve had to take into account and what it’s cost them financially and emotionally.